# Effectiveness of Rifabutin for Treatment of Helicobacter Pylori

> **NCT04652284** · PHASE3 · UNKNOWN · sponsor: **Rabin Medical Center** · enrollment: 300 (estimated)

## Conditions studied

- Helicobacter Infections
- Resistance Bacterial
- Gastritis H Pylori

## Interventions

- **DRUG:** Rifabutin
- **DRUG:** Amoxicillin
- **DRUG:** Esomeprazole
- **DRUG:** Clarithromycin
- **DRUG:** Tinidazole

## Key facts

- **NCT ID:** NCT04652284
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-01
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04652284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04652284, "Effectiveness of Rifabutin for Treatment of Helicobacter Pylori". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04652284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*